Keep up to date with what we're working on!
Fremont, CA January 10, 2020 – Bionova Scientific, a biologics CDMO with deep process development expertise, announced today that Bruce Frazier has joined the company as Vice President of Business Development and Sales. Mr. Frazier will be responsible for developing new business opportunities and managing client relationships
Prior to joining Bionova, Mr. Frazier spent nine years in various business development roles at Boehringer Ingelheim (BI) in Fremont, California. Most recently, he was Director of Business and Contracts, with responsibility for leading the Fremont Business & Contracts team, growing BI’s portfolio of late-stage products and supporting key accounts. He brings more than 20 years of biopharma industry experience, including 13 years in CDMO/CRO business development and sales roles. Bruce held previous positions with Laureate BioPharma, Charles River Labs and Avid Bioservices.
“We are thrilled to have a seasoned and respected industry expert like Bruce leading Bionova’s growth efforts and client relationships,” said Bionova CEO Amy Kong. “He brings excellent technical and operational experience, which we believe are critical in working with clients on new and existing programs. We view his decision to join Bionova at this important stage of our growth as an endorsement of the position we have been working hard to achieve as a go-to resource for challenging biologics development projects.”
Frazier added, “I am looking forward to playing a key role in an exciting company like Bionova. The technical depth of their team is on par with the top tier CDMOs, yet the organization enjoys a nimble, customer-first culture that clients love. With the introduction of cGMP manufacturing later this year, I look forward to introducing Bionova to an industry that will embrace its capabilities.”
Bionova Scientific is based in Fremont, California.
Bionova offers world-class biologics CDMO services built on a foundation of strong process development and analytical science based on decades of experience in late stage and commercial launch projects. We firmly believe that a robust, well-understood process and well-characterized molecule are critical cornerstones of your molecule’s success. Our upstream PD group, with more than 60 benchtop bioreactors, offers a breadth and depth of capability typically found at only the very largest service companies. Bionova takes an expansive view at solving client process problems. Our Fremont, California headquarters includes a 57,000 sq. ft. facility where we will launch our new cGMP biologics manufacturing operation in Q4/2020.